View Press Releases
-
Alfa Chemistry Unveils Its Range of Dietary Supplements: Fruit Juice Powder, Enzyme Powder, and Probiotics Product
In recent years, the demand for dietary supplements has been on the rise as more and more individuals seek to maintain a healthy lifestyle. Alfa Chemistry, a renowned chemical supplier, has unveiled its selection of dietary supplements, offering consumers a wide range of options to support their nutritional needs. With its new product line, including Fruit Juice Powder, Enzyme Powder, and Probiotics Product, Alfa Chemistry aims to provide natural and effective solutions for various health concerns.
Feb 26, 2024
-
Validated AI-Driven Target Identification and Biomarker Discovery with Insilico Medicine’s PandaOmics
PandaOmics is a cloud-based software platform from clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine that helps researchers identify therapeutic targets and discover new biomarkers in order to select the most promising targets to pursue based on all available data and pre-existing research. A new paper in the Journal of Chemical Information and Modeling provides definitive validation of this software platform.
Feb 25, 2024
-
From Simple Dressings to Smart Technology: The Rise of Smart Bandages in the Healthcare Landscape
Driven by the rise of chronic wounds, particularly those linked to diabetes, the healthcare industry sees a surge in innovative smart bandages. These advanced dressings offer faster healing, infection control, and real-time monitoring compared to traditional methods.
Feb 25, 2024
-
AVIA’s Generative AI Strategic Collaborative Highlights Six-Month Milestones And Outlines Next Steps For Pioneering Initiative
-
Backed by Leading Health Systems, Vale Health Launches at Vive 2024; Wellness Marketplace Platform Enables Self-Directed Access to Vetted Products
-
Creative Proteomics Expands Its Epigenetics Portfolio with Advanced Histone PTMs Analysis Service
-
Creative Proteomics Unveils Comprehensive Exosome Lipidomics Services
-
Alfa Chemistry Expands Selection of Click Chemistry Reagents: DBCO, BCN, and Tetrazines Included
-
Creative Proteomics Enhances Research Capabilities with Urine Untargeted Metabolomics
-
Matexcel Enlarged Its Offerings for Pure Metal Powders for Research Use
-
Creative BioMart Launches Protein-Lipids-Nucleic Acid Interaction Assay and Screening Services
-
25m Health Partners with Clearwater to Develop a Scalable Cybersecurity and Compliance Program Across its Portfolio
-
Profacgen Launches Fluorescence Polarization Assay for Advanced Protein Interaction Analysis
-
BioIVT Announces Expansive Fresh Leukopak Capability in Europe
-
Sunbird Bio to Present Positive Data from APEX Alzheimer’s Disease Diagnostic Platform at AD/PD™ 2024
Sunbird Bio announced that new data from a study evaluating its APEX diagnostic platform in Alzheimer’s disease will be presented at the upcoming AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s Disease, taking place March 5-9, 2024.
Feb 21, 2024
-
Huateng Pharma Introduces Semaglutide Side Chain
Huateng Pharma offer Semaglutide Side Chain AEEA-AEEA (CAS NO.: 1143516-05-5), SNAC (CAS NO.: 203787-91-1), tBuO-Ste-Glu(AEEA-AEEA)-OtBu (CAS NO.:1118767-16-0), and Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH (CAS NO.: 1662688-20-1).
Feb 22, 2024
-
Nominations Open for DrFirst’s 2024 Healthiverse Heroes Award
Nominations Open for DrFirst’s 2024 Healthiverse Heroes Award
Feb 22, 2024
-
Lancet Digital Health Publishes Study Confirming MAGENTIQ-COLO™ AI-aided Colonoscopy Technology Improves Adenoma Detection Rates
Lancet Digital Health Publishes Study Confirming MAGENTIQ-COLO™ AI-aided Colonoscopy Technology Improves Adenoma Detection Rates
Feb 22, 2024
-
Cresset® Announces Global Collaboration with Enamine on New Virtual Screening Drug Discovery Technology
Drug discovery specialists Cresset have signed an international collaboration agreement with top global chemical building block providers Enamine to develop new drug discovery technology that can help identify viable drug candidates and unlock future treatment options.
Feb 22, 2024
-
Biotium Expands Selection of Novel Nuclear Stains for Enhanced Multiplexing Flexibility for Microscopy and Flow Cytometry Applications
Biotium has announced the expansion of its NucSpot® Nuclear Stains lineup, offering unprecedented specificity and flexibility for nuclear counterstaining.
Feb 20, 2024